NM_001128590.3:c.242_249delGAGACTAC

Subject ID	Country of Origin	Allele Count	CTGA Clinical Significance	Condition(s)	Reference	Remarks
201910.17	Lebanon	1	Pathogenic	Adrenal Hyperplasia, Congenital, due to 21-Hydroxylase Deficiency	Delague et al, 2000	Compound heterozygote
201910.22.1	Lebanon	2	Pathogenic	Adrenal Hyperplasia, Congenital, due to 21-Hydroxylase Deficiency	Delague et al, 2000
201910.22.2	Lebanon	2	Pathogenic	Adrenal Hyperplasia, Congenital, due to 21-Hydroxylase Deficiency	Delague et al, 2000	Sister of 201910.22.1
201910.31.1	Lebanon	1	Pathogenic	Adrenal Hyperplasia, Congenital, due to 21-Hydroxylase Deficiency	Delague et al, 2000
201910.31.2	Lebanon	1	Pathogenic	Adrenal Hyperplasia, Congenital, due to 21-Hydroxylase Deficiency	Delague et al, 2000	Sibling of 201910.31.1

Epidemiology in the Arab World